These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 34067647)

  • 21. The utility of ALS staging systems in a multi-ethnic patient cohort.
    Abdul Aziz NA; Toh TH; Loh EC; Capelle DP; Goh KJ; Abdul Latif L; Chung TY; Shahrizaila N
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Aug; 22(5-6):341-349. PubMed ID: 33726578
    [No Abstract]   [Full Text] [Related]  

  • 22. Ocular Involvement Occurs Frequently at All Stages of Amyotrophic Lateral Sclerosis: Preliminary Experience in a Large Italian Cohort.
    Cozza F; Lizio A; Greco LC; Bona S; Donvito G; Carraro E; Tavazzi S; Ticozzi N; Poletti B; Sansone VA; Lunetta C
    J Clin Neurol; 2021 Jan; 17(1):96-105. PubMed ID: 33480204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A nerve conduction study predicts the prognosis of sporadic amyotrophic lateral sclerosis.
    Imai E; Nakamura T; Atsuta N; Nakatochi M; Suzuki M; Harada Y; Nakamura R; Hayashi N; Sobue G; Katsuno M
    J Neurol; 2020 Sep; 267(9):2524-2532. PubMed ID: 32367295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Revised amyotrophic lateral sclerosis functional rating scale at time of diagnosis predicts survival time in amyotrophic lateral sclerosis].
    Liu XX; Fan DS; Zhang J; Zhang S; Zheng JY
    Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2472-5. PubMed ID: 20137433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients.
    Watanabe H; Atsuta N; Nakamura R; Hirakawa A; Watanabe H; Ito M; Senda J; Katsuno M; Izumi Y; Morita M; Tomiyama H; Taniguchi A; Aiba I; Abe K; Mizoguchi K; Oda M; Kano O; Okamoto K; Kuwabara S; Hasegawa K; Imai T; Aoki M; Tsuji S; Nakano I; Kaji R; Sobue G
    Amyotroph Lateral Scler Frontotemporal Degener; 2015 Jun; 16(3-4):230-6. PubMed ID: 25548957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The progressive loss of brain network fingerprints in Amyotrophic Lateral Sclerosis predicts clinical impairment.
    Romano A; Trosi Lopez E; Liparoti M; Polverino A; Minino R; Trojsi F; Bonavita S; Mandolesi L; Granata C; Amico E; Sorrentino G; Sorrentino P
    Neuroimage Clin; 2022; 35():103095. PubMed ID: 35764029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
    Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity in ALSFRS-R decline and survival: a population-based study in Italy.
    Mandrioli J; Biguzzi S; Guidi C; Sette E; Terlizzi E; Ravasio A; Casmiro M; Salvi F; Liguori R; Rizzi R; Pietrini V; Borghi A; Rinaldi R; Fini N; Chierici E; Santangelo M; Granieri E; Mussuto V; De Pasqua S; Georgoulopoulou E; Fasano A; ; Ferro S; D'Alessandro R
    Neurol Sci; 2015 Dec; 36(12):2243-52. PubMed ID: 26205535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frontal lobe function and behavioral changes in amyotrophic lateral sclerosis: a study from Southwest China.
    Wei Q; Chen X; Zheng Z; Huang R; Guo X; Cao B; Zhao B; Shang HF
    J Neurol; 2014 Dec; 261(12):2393-400. PubMed ID: 25249295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal comparison of the self-entry Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-RSE) and Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) as outcome measures in people with amyotrophic lateral sclerosis.
    Johnson SA; Burke KM; Scheier ZA; Keegan MA; Clark AP; Chan J; Fournier CN; Berry JD
    Muscle Nerve; 2022 Oct; 66(4):495-502. PubMed ID: 35904151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease progression in
    Floeter MK; Traynor BJ; Farren J; Braun LE; Tierney M; Wiggs EA; Wu T
    Neurology; 2017 Jul; 89(3):234-241. PubMed ID: 28615433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Plasma and salivary acetylcholinesterase activity in amyotrophic lateral sclerosis].
    Khabibrakhmanov AN; Zueva IV; Petrov KA; Bogdanov EI; Mukhamedyarov MA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(1):128-134. PubMed ID: 38261295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and Validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS).
    Fournier CN; Bedlack R; Quinn C; Russell J; Beckwith D; Kaminski KH; Tyor W; Hertzberg V; James V; Polak M; Glass JD
    JAMA Neurol; 2020 Apr; 77(4):480-488. PubMed ID: 31886839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health Status Perspectives in Amyotrophic Lateral Sclerosis.
    Pinto S; de Carvalho M
    Neurodegener Dis; 2017; 17(6):323-329. PubMed ID: 29084402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease progression impacts health-related quality of life in amyotrophic lateral sclerosis.
    Prell T; Gaur N; Stubendorff B; Rödiger A; Witte OW; Grosskreutz J
    J Neurol Sci; 2019 Feb; 397():92-95. PubMed ID: 30597420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial).
    Bella ED; Tramacere I; Antonini G; Borghero G; Capasso M; Caponnetto C; Chiò A; Corbo M; Eleopra R; Filosto M; Giannini F; Granieri E; Bella V; Lunetta C; Mandrioli J; Mazzini L; Messina S; Monsurrò MR; Mora G; Riva N; Rizzi R; Siciliano G; Silani V; Simone I; Sorarù G; Volanti P; Lauria G
    BMJ Open; 2017 Aug; 7(8):e015434. PubMed ID: 28801400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Staging amyotrophic lateral sclerosis: A new focus on progression.
    Corcia P; Beltran S; Lautrette G; Bakkouche S; Couratier P
    Rev Neurol (Paris); 2019 May; 175(5):277-282. PubMed ID: 30606512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A role for functional classification in the early identification of prognostic factors in ALS.
    Rauchway AC; Kaiboriboon K; Bansal SK; Kulkantrakorn K; Guo X; Parks BJ; Hayat GR
    Amyotroph Lateral Scler; 2007 Aug; 8(4):214-6. PubMed ID: 17653918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malnutrition at diagnosis in amyotrophic lateral sclerosis (als) and its influence on survival: Using glim criteria.
    López-Gómez JJ; Ballesteros-Pomar MD; Torres-Torres B; De la Maza BP; Penacho-Lázaro MÁ; Palacio-Mures JM; Abreu-Padín C; López-Guzmán A; De Luis-Román DA
    Clin Nutr; 2021 Jan; 40(1):237-244. PubMed ID: 32507583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the factorial validity and reliability of the ALSFRS-R: a revision of its measurement model.
    Bakker LA; Schröder CD; van Es MA; Westers P; Visser-Meily JMA; van den Berg LH
    J Neurol; 2017 Jul; 264(7):1413-1420. PubMed ID: 28608303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.